The Firm is representing Blackstone, Carlyle and Hellman & Friedman in connection with their proposed majority investment in Medline Industries, Inc. The investment is expected to be completed in late 2021 and is subject to regulatory approvals and customary closing conditions. Following the close of the transaction, Medline will remain a privately held, family-led company. Financial terms of the transaction were not disclosed.
Medline is the nation’s largest privately held manufacturer and distributor of healthcare supplies with 2020 revenue of $17.5 billion.
The Simpson Thacher team includes Elizabeth Cooper, Naveed Anwar, Atif Azher, Anthony Vernace, Ravi Purushotham, Michael Chao, Mark Myott, Jacob Gindt and Marina Hernandez (M&A); Alden Millard, Brian Steinhardt, Brian Gluck, Adam Moss and Kyle Nelson (Banking and Credit); Bill Brentani, Dan Webb, Jon Ozner and Estell Lee (Capital Markets); Greg Grogan, Jeannine McSweeney, Joo Hyun Lee, Allison Sweeney and Guanxiong Xu (Executive Compensation and Employee Benefits); Jonathan Goldstein, Sophie Staples, Russell Light and Abigail Hopper (Tax); Erik Quarfordt, Krista McManus and Matthew Freeze (Real Estate); Barrie Covit, Jonathan Karen, David Greene, Steven Klar and Robert Guo (Funds); Lori Lesser, Melanie Jolson and Bobbie Burrows (Intellectual Property); and Peter Guryan, Rick Jamgochian and Max Fischer-Zernin (Antitrust).